(Total Views: 496)
Posted On: 12/11/2019 12:06:44 PM
Post# of 30
RALLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY
IPCIF =Price 0.28--MC $7 M --ADCOM meeting mid next month --Abuse Deterrent Pain Drug =2000% POTENTIAL if positive outcome...Drug has $400 million commercial opportunity = A MEGA LIFETIME OPP ..
Intellipharmaceutics Announces FDA Advisory Committee Meeting for Aximris XR(TM) (Oxycodone Hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
https://finance.yahoo.com/news/intellipharmac...00667.html
IPCIF =Price 0.28--MC $7 M --ADCOM meeting mid next month --Abuse Deterrent Pain Drug =2000% POTENTIAL if positive outcome...Drug has $400 million commercial opportunity = A MEGA LIFETIME OPP ..
Intellipharmaceutics Announces FDA Advisory Committee Meeting for Aximris XR(TM) (Oxycodone Hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
https://finance.yahoo.com/news/intellipharmac...00667.html
(0)
(0)Scroll down for more posts ▼
